Attached files
| file | filename |
|---|---|
| 10-K - NEKTAR THERAPEUTICS | v176023_10k.htm |
| EX-3.6 - NEKTAR THERAPEUTICS | v176023_ex3-6.htm |
| EX-32.1 - NEKTAR THERAPEUTICS | v176023_ex32-1.htm |
| EX-23.1 - NEKTAR THERAPEUTICS | v176023_ex23-1.htm |
| EX-31.1 - NEKTAR THERAPEUTICS | v176023_ex31-1.htm |
| EX-31.2 - NEKTAR THERAPEUTICS | v176023_ex31-2.htm |
| EX-10.16 - NEKTAR THERAPEUTICS | v176023_ex10-16.htm |
Exhibit 21.1
Subsidiaries
of Nektar Therapeutics*
|
Name
|
Jurisdiction of
Incorporation or
Organization
|
|
|
Nektar
Therapeutics UK, Ltd.
|
United
Kingdom
|
|
|
Inhale
Therapeutic Systems Deutschland GmbH
|
Germany
|
|
|
Nektar
Therapeutics (India) Pvt. Ltd
|
India
|
|
|
Aerogen,
Inc.
|
Delaware
|
|
*
|
Includes
subsidiaries that do not fall under the definition of “Significant
Subsidiary” as defined under Rule 1-02(w) of Regulation
S-X.
|